Adenosine A(2A)-dopamine D(2) receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics

Podobne zapisy

• Adenosine A(1)-A(2A) Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease
  od: Fernández-Dueñas, Víctor, i wsp.
  Wydane: (2017)
• Adenosine Receptor Heteromers and their Integrative Role in Striatal Function
  od: Ferré, Sergi, i wsp.
  Wydane: (2007)
• Adenosine Receptor Heteromers and their Integrative Role in Striatal Function
  od: Sergi Ferré, i wsp.
  Wydane: (2007-01-01)
• Functional and Neuroprotective Role of Striatal Adenosine A(2A) Receptor Heterotetramers
  od: Ferré, Sergi, i wsp.
  Wydane: (2019)
• Revealing Adenosine A(2A)-Dopamine D(2) Receptor Heteromers in Parkinson’s Disease Post-Mortem Brain through a New AlphaScreen-Based Assay
  od: Fernández-Dueñas, Víctor, i wsp.
  Wydane: (2019)